BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medical Diagnostic

Pfizer And Astellas Report Strong Phase III EV 304 Results For PADCEV Plus Pembrolizumab In MIBC

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with ove...

March 02, 2026 | News

Optellum Secures TGA Approval In Australia For AI Powered Virtual Nodule Clinic

Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration ...

March 02, 2026 | News

Brainlab And Precision NeuroMed Partner To Advance AI Enabled Convection Enhanced Delivery Platform

Brainlab SE (Brainlab), a digital medical technology company automating and optimizing clinical workflows using artificial intelligence and sophistica...

February 27, 2026 | News

Gilead Reports Positive Phase 3 Data For Investigational Bictegravir And Lenacapavir Single Tablet Regimen

– Novel Investigational Combination Pairs Bictegravir, a Global Guideline-Recommended Integrase Strand Transfer Inhibitor with a High Barrier ...

February 27, 2026 | News

Bioxytran Initiates University Of Georgia Collaboration Under 100 Million Dollar Grant To Target H5N1 Bird Flu

Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company developing breakthrough antiviral treatments, announced it has initiated a research c...

February 24, 2026 | News

CStone Secures UK MHRA Approval For Sugemalimab In Stage III Non Small Cell Lung Cancer

Following approval by the European Commission (EC), sugemalimab has received a new indication approval from the UK Medicines and Healthcare products...

February 24, 2026 | News

YolTech Reports Positive Interim Data For YOLT 202 In Alpha 1 Antitrypsin Deficiency

Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated with ...

February 23, 2026 | News

ANKTIVA Plus BCG Secures European Commission Authorization As First Immunotherapy For BCG Unresponsive NMIBC

ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive blad...

February 20, 2026 | News

Copan Secures FDA 510(k) Clearance For PhenoMATRIX AI Driven Culture Plate Assessment Software

Copan Group announced that PhenoMATRIX®, its automated image assessment software used with WASPLab® full laboratory automation, rece...

February 19, 2026 | News

QuidelOrtho Signs Strategic Supply Agreement With Lifotronic Technology To Expand Global Immunoassay Portfolio

Agreement adds new analyzer platforms and expands assay menu across key international markets QuidelOrtho has entered a long-term strategic supply agreeme...

February 18, 2026 | News

Beactica Therapeutics AB Secures EUR 2.5 Million EIC Grant To Advance Precision Immune Therapy For Glioblastoma

Beactica Therapeutics AB, a Swedish precision medicine company, announced that it, together with leading glioblastoma researchers at KU Leuven, has been aw...

February 18, 2026 | News

Bio Techne Corporation Announces CE IVD Marking For Ella Benchtop Immunoassay Platform In European Union

Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform tha...

February 18, 2026 | News

QIAGEN Study Shows QuantiFERON TB Gold Plus Improves Cost Effectiveness Of HIV TB Screening In Thailand

Peer-reviewed health-economic analysis evaluates tuberculosis infection (TBI) screening strategies among people living with HIV in Thailand Quanti...

February 13, 2026 | News

Berlin Heals Secures Over USD 10 Million To Advance Cardiac Microcurrent Therapy For Heart Failure

Berlin Heals Holding AG, a MedTech company focused on transformative therapies for heart failure, announced the successful closing of a new financing ...

February 13, 2026 | News

Stay Connected